Cargando…
Rivaroxaban administration after acute ischemic stroke: The RELAXED study
The efficacy of early anticoagulation in acute stroke with nonvalvular atrial fibrillation (NVAF) remains unclear. We performed a study to evaluate the risk of recurrent ischemic stroke (IS) and major bleeding in acute IS patients with NVAF who started rivaroxaban. This observational study evaluated...
Autores principales: | Yasaka, Masahiro, Minematsu, Kazuo, Toyoda, Kazunori, Mori, Etsuro, Hirano, Teruyuki, Hamasaki, Toshimitsu, Yamagami, Hiroshi, Nagao, Takehiko, Yoshimura, Shinichi, Uchiyama, Shinichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373970/ https://www.ncbi.nlm.nih.gov/pubmed/30759158 http://dx.doi.org/10.1371/journal.pone.0212354 |
Ejemplares similares
-
Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation
por: Koge, Junpei, et al.
Publicado: (2022) -
Practical “1-2-3-4-Day” Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study
por: Kimura, Shunsuke, et al.
Publicado: (2022) -
Anticoagulation Intensity of Rivaroxaban for Stroke Patients at a Special Low Dosage in Japan
por: Okata, Takuya, et al.
Publicado: (2014) -
Efficacy and Safety of Prasugrel by Stroke Subtype: A Sub-Analysis of the PRASTRO-I Randomized Controlled Trial
por: Kitazono, Takanari, et al.
Publicado: (2021) -
Clinical Characteristics of Transient Ischemic Attack Patients with Atrial Fibrillation: Analyses of a Multicenter Retrospective Study
por: Hama, Yuka, et al.
Publicado: (2015)